Search research articles
Contact Us
Filters
Showing results (261-270 of 274) with videos related to
Page
of 28
Sort By:
Vaccines
|
May 7, 2025
Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies
Anna Sicuranza, Massimo Breccia, Francesco Iuliano, et al.
JAMA Internal Medicine
|
July 14, 2015
Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry
Walter Ageno, Nicoletta Riva, Sam Schulman, et al.
Blood Advances
|
November 13, 2024
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study
Bruno Fattizzo, Alfredo Marchetti, Alessandro Bosi, et al.
Blood Advances
|
November 8, 2019
Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patients
Margherita Maffioli, Toni Giorgino, Barbara Mora, et al.
Journal for Immunotherapy of Cancer
|
March 6, 2019
α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas
E Dodagatta-Marri, D S Meyer, M Q Reeves, et al.
NPJ Genomic Medicine
|
October 29, 2024
SLC16A8 is a causal contributor to age-related macular degeneration risk
Navid Nouri, Bailey Hannon Gussler, Amy Stockwell, et al.
Influenza and Other Respiratory Viruses
|
December 1, 2025
Nirsevimab Effectiveness Against RSV-Related Hospitalisations in Children Under 24 Months: A Test-Negative Case-Control Study in Portugal, 2024-2025
Vânia Gaio, Camila Henriques, Miguel Lança, et al.
Water Research X
|
December 15, 2023
Mitigating risks and maximizing sustainability of treated wastewater reuse for irrigation
David Yalin, Hillary A Craddock, Shmuel Assouline, et al.
Cancer
|
June 24, 2023
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML
Mario Tiribelli, Roberto Latagliata, Massimo Breccia, et al.
European Journal of Haematology
|
September 12, 2024
Choice of Frontline Tyrosine-Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A "Campus CML" Study
C Bucelli, I Capodanno, M C Miggiano, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 274) with videos related to
Sort By:
Page
of 28
Vaccines
|
May 7, 2025
Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies
Anna Sicuranza, Massimo Breccia, Francesco Iuliano, et al.
JAMA Internal Medicine
|
July 14, 2015
Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry
Walter Ageno, Nicoletta Riva, Sam Schulman, et al.
Blood Advances
|
November 13, 2024
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study
Bruno Fattizzo, Alfredo Marchetti, Alessandro Bosi, et al.
Blood Advances
|
November 8, 2019
Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patients
Margherita Maffioli, Toni Giorgino, Barbara Mora, et al.
Journal for Immunotherapy of Cancer
|
March 6, 2019
α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas
E Dodagatta-Marri, D S Meyer, M Q Reeves, et al.
NPJ Genomic Medicine
|
October 29, 2024
SLC16A8 is a causal contributor to age-related macular degeneration risk
Navid Nouri, Bailey Hannon Gussler, Amy Stockwell, et al.
Influenza and Other Respiratory Viruses
|
December 1, 2025
Nirsevimab Effectiveness Against RSV-Related Hospitalisations in Children Under 24 Months: A Test-Negative Case-Control Study in Portugal, 2024-2025
Vânia Gaio, Camila Henriques, Miguel Lança, et al.
Water Research X
|
December 15, 2023
Mitigating risks and maximizing sustainability of treated wastewater reuse for irrigation
David Yalin, Hillary A Craddock, Shmuel Assouline, et al.
Cancer
|
June 24, 2023
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML
Mario Tiribelli, Roberto Latagliata, Massimo Breccia, et al.
European Journal of Haematology
|
September 12, 2024
Choice of Frontline Tyrosine-Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A "Campus CML" Study
C Bucelli, I Capodanno, M C Miggiano, et al.
Page
of 28